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Recommendations for improving 
accuracy of gene expression 
data in bone and cartilage tissue 
engineering
Tao He1,2, Yijiang Huang1, Juy Chi Chak1 & Roland Manfred Klar1
Autogenous tissue grafting remains the gold standard in the treatment of critical sized bone and certain 
cartilage defects, while the translation of tissue engineered osteogenesis or chondrogenesis from the 
lab bench into clinical practice, utilizing natural or synthetic biomimetic devices, remains challenging. 
One of the crucial underestimated reasons for non-translatability could be the imprecision and 
inconsistency of generated gene expression profiles, utilizing improperly optimized and standardized 
quantitative gene assays. Utilizing GeNorm for downstream qRT-PCR applications, the stability of 
reference genes in relation to optimal cDNA amounts was assessed on human bone marrow-derived 
mesenchymal and adipose-derived stem cells neat and made to differentiate into chondrocytes 
including normal human derived chondrocytes and muscle tissue from rats. Results showed that 
reference genes can vary substantially across separately and/or combined cell lines and/or tissue types 
including treatment parameters. The recommendations to all bone and cartilage tissue engineers 
utilizing qRT-PCR is not to assume that reference gene stability and quantity remain conserved 
across cell lines or tissue types but to always determine, for each new experiment, the stability and 
normalization quantity of reference genes anew.
After more than a century, clinical bone regenerative procedures still rely on autogenous bone grafting1–3 to heal 
and regenerate large bone defects in human. Similarly, damaged cartilage caused either by osteoarthritis or inten-
sive sports are still being treated by varying surgically invasive procedures with limited regenerative techniques 
being unable to heal critical defects4–9. Whilst some progress has been made in our understanding in some of 
the molecular mechanisms and how bone and cartilage formation can be induced experimentally the concept of 
either regenerating defects or complete re-growth of the damaged osteogenic or chondrogenic material remains 
problematic10–20. One factor not often considered is the variety of analytical methodologies used to monitor gene 
expression patterns and their subsequent translation, which are deciding factors for generating realistic mecha-
nistic molecular insights in how regenerative processes function and how to modulate them.
Real-time reverse transcription quantitative polymerase chain reaction (qRT-PCR) has become the leading 
analytic technique, and is an economical, jet simple and highly effective method for monitoring gene transcrip-
tion, which over the last two decades has made considerable progress at improving the accuracy of gene expres-
sion data21–31. Quantitative real-time PCR remains the best alternative to new emerging techniques such as digital 
droplet PCR and Next Generation Sequencing that are often very expensive to perform. Whilst some bone and 
cartilage research groups have already used the new standards as set out by Bustin et al.27 pioneering “Minimum 
Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines”20,27,32–34, a con-
siderable number of research groups still rely on outdated and highly insufficient qRT-PCR techniques; when 
combined with insufficient experimental detail, these techniques render replication of many published findings 
challenging35 and questionable. The lack of accurate and reproducible gene expression data could be one of the 
factors contributing to the failing or weak translatability of the in vitro to in vivo to the clinical context, thereby 
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preventing regenerative therapies from replacing the gold standards currently employed to treat bone and carti-
lage damage and defects.
Results
cDNA amount dependent reference genes expression. In all cell lines and tissue included in the 
present study, the mean Cq of RNA28S was the lowest (Table 1). For human bone-derived mesenchymal stem 
cells (hBMSCs), the mean Cq of RPL13a was consistent with complementary DNA (cDNA) quantity ranging 
from 2.5 ng to 40 ng (20.03 ± 0.68); the mean Cq of SDHA, TBP, RNA28S4, GAPDH, and RPLP0 decreased as 
the amount of cDNA increased; the mean Cq of POLR2e and ACTB increased as the amount of cDNA increased 
(Table 1). For human adipose-derived mesenchymal stem cells (hADSCs) and human chondrocytes, the mean 
threshold cycle of all eight candidate reference genes decreased as the amount of cDNA increased. The two ref-
erence genes with the highest mean Cq were SDHA and TBP (Table 1). Interestingly, for the rat rectus abdominis 
muscle, the mean threshold cycle of TBP and GAPDH remained constant independently of the cDNA quantity 
utilized (26.46 ± 0.96, and 26.64 ± 0.24 respectively); the mean Cq of POLR2e and RNA28S4 decreased as the 
amount of cDNA increased for the muscle tissue with the mean Cq of SDHA, ACTB, RPL13a, and RPLP0 increas-
ing as the amount of cDNA increased (Table 1). Optimum cDNA quantity, to use for all other qRT-PCR applica-
tions, was determined to be between 2.5 ng to 10 ng which permits for maximum usage of reference genes and test 
genes to be used during qRT-PCR assays without waste of RNA or subsequent cDNA.
Stability and optimal number of reference gene(s) expression. Cells were assessed separately, in 
combination for a single cell or tissue type, differentiated or undifferentiated, or as a total combination of all 
cells and tissue types. The different analyses represent different hypothetical experimental scenarios that could 
come about during a study. Scenarios are divided into: hBMSCs normal and differentiated into chondrocytes; 
Reference Gene Cell/Tissue Type
Cq at cDNA quantity
2.5 ng 5 ng 10 ng 20 ng 40 ng
SDHA
hMSCs (Chond.) 25.52 24.45 23.72 22.94 22.66
hADSCs (Chond.) 27.07 26.09 24.98 24.03 23.07
hChond. 26.94 25.82 24.63 23.51 22.74
Muscle tissue (rat) 22.63 21.51 20.77 21.18 25.89
POLR2e
hMSCs (Chond.) 25.13 23.90 23.03 22.21 29.57
hADSCs (Chond.) 27.75 26.37 25.49 24.42 24.23
hChond. 23.60 22.98 21.38 20.42 19.88
Muscle tissue (rat) 23.91 22.92 22.34 21.61 22.35
TBP
hMSCs (Chond.) 28.02 26.73 26.02 25.34 25.77
hADSCs (Chond.) 28.07 27.10 26.10 25.21 24.04
hChond. 26.06 25.09 24.05 22.91 21.9
Muscle tissue (rat) 27.40 26.44 25.70 25.33 27.43
ACTB
hMSCs (Chond.) 17.10 16.02 15.48 16.51 23.83
hADSCs (Chond.) 25.45 23.96 22.73 21.81 21.19
hChond. 16.94 15.83 14.86 13.82 12.80
Muscle tissue (rat) 22.26 21.07 20.93 20.89 23.59
RPL13a
hMSCs (Chond.) 20.72 19.88 20.22 18.94 20.39
hADSCs (Chond.) 18.26 17.03 15.90 14.99 13.85
hChond. 19.83 18.71 17.45 16.68 15.82
Muscle tissue (rat) 20.83 20.10 20.04 19.99 22.18
RNA28S4
hMSCs (Chond.) 12.63 11.38 10.63 9.76 8.93
hADSCs (Chond.) 13.95 12.84 11.93 10.82 11.30
hChond. 12.70 11.70 10.62 9.81 8.98
Muscle tissue (rat) 12.60 11.63 10.26 8.93 8.98
GAPDH
hMSCs (Chond.) 19.48 18.38 17.62 17.07 16.66
hADSCs (Chond.) 23.04 22.02 20.55 19.60 18.53
hChond. 18.31 17.12 16.02 15.08 14.10
Muscle tissue (rat) 26.78 26.49 26.31 26.93 26.69
RPLP0
hMSCs (Chond.) 20.70 19.56 19.06 18.59 18.75
hADSCs (Chond.) 25.32 24.07 22.87 21.93 21.39
hChond 19.07 17.26 16.37 15.40 14.81
Muscle tissue (rat) 26.80 25.99 25.77 26.35 29.82
Table 1. Mean threshold cycle (Cq) of reference genes in a 2x dilution series of cDNA quantities from 
chondrogenic hMSCs (Chond.), hADSCs (Chond.), normal human chondrocytes (hChond.) and muscle tissue 
from rat.
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hADSCs normal and differentiated into chondrocytes; normal chondrocytes and normal chondrocytes treated 
(made apoptotic); hADSCs/differentiated hADSCs with hBMSCs/differentiated hBMSCs with normal/treated 
chondrocytes with the final scenario being rat muscle tissue normal and osteogenic medium treatment.
hBMSCs and chondrogenic hBMSCs. GeNorm analysis was carried out singly for hBMSCs and hBMSCs differ-
entiated into chondrocytes including both types of cell types combined (Fig. 1A–C). For undifferentiated hBM-
SCs the most stable expressed reference primers were TBP, GAPDH, ACTB and POLR2e (Fig. 1A1), with SDHA, 
ACTB, RNA28S4 and RPLP0 being the reference genes with the best stability in hBMSCs that had undergone 
chondrogenic differentiation (Fig. 1B1). When both cell types were assessed in combination, using GeNorm, 
SDHA, ACTB, RPL13a and GAPDH were most stably expressed (Fig. 1C1). With respect to the optimal number 
of reference genes necessary for normalization, results showed that 2 to 3 reference genes were sufficient for both 
single and combined GeNorm analysis sets (Fig. 1A2–C2).
Figure 1. Average expression stability (A1,B1,C1) and optimal number of reference genes for normalization 
(A2,B2,C2) for qRT-PCR assays, utilizing the GeNorm algorithm, for (A) normal hBMSCs and (B) 
chondrogenic differentiated hBMSCs separately or (C) both cell lines combined.
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hADSCs and chondrogenic hADSCs. As shown in Fig. 2, the optimal number of reference genes to use for nor-
malization during a qRT-PCR analysis was 5 to 6 for the hADSCs group singly, 2 to 3 in chondrogenic hADSCs 
singly and 4 to 5 when both hADSCs normal/differentiated were analyzed together utilizing GeNorm, respectively 
(Fig. 2A2–C2). The reference gene expression stability of untreated hADSCs, chondrogenic hADSCs or combined 
GeNorm analysis sets generated similar results, in which TBP, SDHA, POLR2e, RPLP0 and ACTB/GAPDH were 
among the most stable reference genes expressed (Fig. 2A1–C1). The order of these reference genes on the sta-
bility scale changed. In general, the highest six reference genes in the ranking of stability were POLR2e, SDHA, 
TBP, RPLP0, GAPDH, and RPL13a in untreated hADSCs; TBP, ACTB, RPLP0, POLR2e, SDHA, and GAPDH in 
chondrogenic hADSCs; TBP, POLR2e, SDHA, RPLP0, GAPDH, and ACTB in combined hADSCs sets.
Normal and treated (apoptotic) chondrocytes. ATDC5 human chondrocytes untreated or made apoptotic (treat-
ment), show that the optimal number of reference genes to use for normalization in qRT-PCR, after GeNorm 
Figure 2. Average expression stability (A1,B1,C1) and optimal number of reference genes for normalization 
(A2,B2,C2) for qRT-PCR assays, utilizing the GeNorm algorithm, for (A) normal hADSCs and (B) 
chondrogenic differentiated hADSCs separately or (C) both untreated and treated hADSCs cell lines combined.
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assessment, is 5 to 6 for untreated chondrocytes, 6 to 7 for the treated chondrocyte group and 4 to 5 when both 
untreated and apoptotic chondrocyte groups are assed together (Fig. 3A2–C2). The reference gene expression sta-
bility order between the different groups remained consistent (Fig. 3A1–C1). The highest seven reference genes in 
the ranking of stability from most to least stable were RPLP0, ACTB, RPL13a, POLR2e, TBP, GAPDH, and SDHA.
Chondrocytes, hBMSCs and hADSCs. For all normal, treated or differentiated cell types, results showed that 
the optimal number of reference genes to use for normalization during a qRT-PCR analysis are 2 to 3 when 
chondrocytes, hBMSCs and hADSCs were looked at in GeNorm, 6 to 7 when treated chondrocytes (apoptotic), 
chondrogenic hBMSCs and chondrogenic hADSCs were assessed with GeNorm and 5 to 6 when all cell groups 
were assessed, respectively (Fig. 4A2–C2). For reference gene expression stability between these different scenario 
groups TBP, POLR2e, GAPDH and RPL13a were the most stable genes in the chondrocyte, hBMSCs and hADSCs 
Figure 3. Average expression stability (A1,B1,C1) and optimal number of reference genes for normalization 
(A2,B2,C2) for qRT-PCR assays, utilizing the GeNorm algorithm, for (A) normal human Chondrocytes 
(hChondrocytes) and (B) hChondrocytes undergoing apoptosis or (C) both normal and apoptotic chondrocyte 
cell lines combined.
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group, GAPDH, RPLP0, TBP and SDHA were the most stable in treated chondrocytes, chondrogenic hBMSCs and 
hADSCs with TBP, GAPDH, RPLP0 and POLR2e being the most stable between all cell groups (Fig. 4A1–C1).
Rattus novericus rectus abdominis muscle normal and osteogenic. Untreated muscle tissue, including muscle tis-
sue that had been stimulated to undergo osteogenic differentiation utilizing osteogenic medium within an in vitro 
culture system, were analyzed separately and combined using GeNorm assessment. Results show that that ref-
erence stability changes considerably when untreated, treated and combined experimental groups were assessed 
(Fig. 5A1–C1), where ranking of the reference gene is concerned on the stability curve. The highest four most 
stable reference genes in untreated rat muscle were TBP, POLR2e, RPLP0, and GAPDH. TBP, RPLP0, POLR2e, 
and SDHA were most stable in the osteogenic treated rat muscle group, whereas RPLP0, SDHA, POLR2e, and TBP 
Figure 4. Average expression stability (A1,B1,C1) and optimal number of reference genes for normalization 
(A2,B2,C2) for qRT-PCR assays, utilizing the GeNorm algorithm. (A) GeNorm results between Control cell 
groups with normal hChondrocytes, hBMSCs and hADSCs. (B) GeNorm results between treated cell groups, 
i.e. hChondrocytes undergoing apoptosis, chondrogenic differentiated hBMSCs and hADSCs. (C) GeNorm 
results between all untreated and treated cell lines and types.
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were in combined rat muscle groups. As for the optimal number of reference genes needed for normalization, 
the results show that 2 to 3 are needed in untreated rat muscle group with 3 to 4 in osteogenic rat muscle or both 
untreated and treatment groups combined (Fig. 5A2–C2). The overall gene expression stability of untreated rat 
muscle was the highest, while osteogenic rat muscle ranked second with the combined groups coming last.
Discussion
The results from the present study clearly show that reference genes in many relative qRT-PCR applications are 
inappropriately used, as the housekeeping gene expression changes between cell and tissue types including how 
these are utilized under various experimental conditions. Reference gene(s) stability varies together with the 
appropriate number of candidate reference genes to use during qRT-PCR gene expression analyses. This can sig-
nificantly alter the gene expression results and subsequent downstream interpretations, consequently reducing 
Figure 5. Average expression stability (A1,B1,C1) and optimal number of reference genes for normalization 
(A2,B2,C2) for qRT-PCR assays, utilizing the GeNorm algorithm, for (A) untreated rat rectus abdominis muscle 
tissue, (B) rat rectus abdominis muscle tissue treated with osteogenic medium, and (C) both normal and treated 
rat muscle tissue.
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the accuracy of gene transcription patterns that are necessary to make appropriate deductions for molecular 
mechanisms in tissue engineering fields.
Regeneration of bone and cartilage tissue without the need for autografting is a promising aspect in medicine. 
However, the translation from in vitro to in vivo and finally into the clinical setting remains problematic and 
challenging36. Results from numerous studies are difficult to interpret or compare with each other as there is a 
considerable heterogeneity in experimental designs. Whether it is different stem cell or cell lines, tissue types, 
varying time points of analysis during experimental setups or the plethora of different treatments, there is cur-
rently no standardized concept in the field of bone and cartilage tissue engineering in the way of methodologies. 
This however is a crucial criterion to ensure that generated data remains consistent and reproducible. One crit-
ical aspect in the “standardization debate” is the generation of accurate gene expression data, as genes control 
life. Understanding the patterns of modulation is critical to successfully regenerate bone, cartilage or any tissue 
type in vivo37. However, few groups do conform to new standards in qRT-PCR applications. The use of validated 
techniques and the quantity of reference genes for normalization remains problematic but are an important cri-
terion without which, the generation of accurate, comparable and reproducible gene expression results cannot 
be obtained, thereby making the generated genetic expression profile of cells or tissue during bone or cartilage 
regenerative procedures results questionable. Whilst more modern techniques exist, they are prohibitively expen-
sive but at the same time require validation through qRT-PCR assays, to determine the validity of generated 
results38,39. As such, if used properly, qRT-PCR remains the best alternative. As of now, variation still exists as 
few studies conform to the new and proven standards by Bustin, Hellemans and Vandesompele27–31. This might 
explain why bone and cartilage regeneration still appear to fail clinically. The present study attempted to optimize 
and validate necessary reference genes for specific cell and tissue types that are most commonly used in bone and 
cartilage tissue engineering studies. What we discovered was a critical aspect in the validation process of reference 
genes to utilize during qRT-PCR experiments and generating the corresponding relative quantitative gene expres-
sion data of test genes, which has to be considered to ensure that future gene expression results would become 
more exact, but more importantly comparable and reproducible.
Reference genes are considered to be genes that are constantly expressed by cells, individually or or within 
tissue40. Various studies have shown that this is not to be taken as a rule as these genes can also be affected by 
treatment modalities41.The recommendations by Bustin et al.27 are to use a minimum of at least 2 reference genes 
during a qRT-PCR run, as the original reference gene of choice could be affected depending on the experiment. 
Our study clearly re-iterated this fact for the GAPDH gene, a very common utilized reference gene in bone and 
cartilage qRT-PCR assays42–44. This gene is considered to be the most “stably” expressed reference gene, with 
many presented experimental publications and groups never deviating or questioning the validity of this concept. 
However, from the results of the present study it is clear that whilst GAPDH can be one of the stably expressed 
reference genes, its position on the stability scale can greatly deviate. This, depending on the quantity of reference 
genes necessary for normalization, can considerably alter the gene expression profile of selected analytical genes 
that an experiment is trying to determine.
GeNorm25, NormFinder45, and BestKeeper46 are currently the three most used algorithms for determining 
the gene expression stability and the quantity of reference genes to use for normalization in qRT-PCR. Given that 
the GeNorm algorithm is highly dependent on the assumption that the reference genes being analyzed are not 
co-regulated45, in the present study an analysis to judge whether co-regulation existed between reference genes, 
was conducted. This way, it can be predicted that if two genes indeed co-regulated each other, when analyzed 
with GeNorm, they would occupy adjacent positions in the ranking47. As such an internal control was performed 
where different reference genes were removed (data not shown). Results validated that the ranking of reference 
genes related to stability and optimal number was not altered, meaning that there was no co-regulation between 
the different genes selected. These findings are supported by previous results where NormFinder and BestKeeper 
algorithms were utilized instead of GeNorm48. Although there have been suggestions to use both GeNorm in 
conjunction with BestKeeper or NormFinder or to only use BestKeeper with NormFinder45–47, the present results 
clearly indicate that irrelevant of the gene stability and quantity determining reference gene programs utilized, 
these will not impact on which reference genes are stable or the optimum number to use in an experiment. The 
GeNorm algorithm can be considered a reliable and very simple method for analyzing gene expression stability 
and determining the optimal number of reference genes for a selected study. Yet, what is of critical importance is 
to not assume that, once a certain reference gene set has been determined for a cell or tissue type within an exper-
iment, such reference genes will always remain stably expressed, when utilizing this same cell or tissue type in 
consecutive experiments. This notion of using reference genes like this49–51 is dangerous and should be evaluated 
carefully in light of the present study’s findings.
Conducting qRT-PCR experiments in light of the new recommendations by Bustin et al.31 sometimes relies 
on optimized kits from various scientific companies or reference genes based on the recommendations from 
other research groups50–53. Care must however be made regarding the methodological steps present in the current 
or past literature, as these are often not detailed enough to allow reproducing experiments. This is particularly 
critical when reporting how the qRT-PCR sections are constructed. A good example, for the tissue engineering 
bone and cartilage fields are the publications by Klar et al.32, Klar et al.20, Ripamonti et al.54, where the qRT-PCR 
sections describe in great detail each step and how the material was optimized20,32,54. If publications do not offer 
this amount of detail, then the material must be carefully considered before use. This is made very clear when 
comparing the GeNorm results, from the present study, to the literature where similar designed studies utilizing 
similar cell types make recommendations to reference gene usage in qRT-PCR based experiments55. Interestingly, 
we discovered that even for a certain cell line with slightly different cell sources, for instance isolated cells from 
human tissue directly versus commercially available cell lines, results were considerably different. Compared to 
the study by Ragni et al.55, in which the study also included TBP, ACTB, RPLP0, GAPDH, and RPL13A as the 
candidate reference genes for chondrogenic human stem cells, the optimal number of reference genes to use was 
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9 to10 in their study, whereas our results suggested a minimum of 4 to a maximum of 5. Subsequently to this, 
the ranking of the reference genes expression stability also varied considerably between these two datasets with 
the sequence from most stable to least stable reference genes being TBP, RPL13A, GAPDH, RPLP0 and ACTB 
from the chosen literature source, whereas in the present studies results it was ACTB, RPLP0, GAPDH, RPL13A 
and TBP. Furthermore, we found that when we put all the different cell groups together, be they untreated or 
treated groups, and assessed these in GeNorm analysis (Fig. 4C1,C2), the generated results of the reference gene 
expression stability versus optimal number of candidate reference genes to use for qRT-PCR applications var-
ied substantially from those where only untreated or treated samples were assessed with each other separately 
(Fig. 4A1,A2,B1,B2). With respect to inductive tissues used for bone or cartilage regeneration, there are also 
considerable differences between in vitro versus in vivo based tissue gene expression patterns51,56–59. For the rectus 
abdominis muscle tissue from rats, since the tissue is comprised of a plethora of different cell layers and cell types, 
the stability of gene expression could be compensated for (Fig. 5), which is not the case for cells in vitro as these 
are often single cell lines lacking the presence of other cell types. However, similar to the patterns shown in cell 
lines of the present study, decreased stability of reference gene expression was also observed in the tissue when 
both untreated and treatment samples were combined in the GeNorm analysis. Similar to cells in vitro, there 
seems to be a pattern in the GeNorm analysis, where the moment the various groups are co-analyzed, the amount 
of reference genes to use to for the normalization varies. As such, it can be implied that subtle differences between 
different datasets can produce considerable variations in the gene expression stability and the optimal number 
of reference genes. From this, we thus make the recommendation not to assume that reference gene stability and 
quantity remains conserved for cell lines or tissue types between experiments but that there is a need to deter-
mine, for each new experiment, the stability and normalization quantity of reference genes anew. We believe that 
failing to do so might result in deviations in gene expression accuracy patterns during downstream analytical 
processes and consequently lead to difficulty in the translation of approaches to a clinical environment.
Of course, it must be said that the reference genes used in the current study are not all the reference genes 
presently available. There are a variety of reference genes produced by cells in addition to the 8 selected for this 
study60. As such we cannot definitively state that the presented reference genes are the most stable reference genes 
for cell types or tissue types in bone or cartilage research. To compensate for this, digital droplet PCR or Next 
Generation Sequencing could be utilized as these techniques eliminate the necessity for utilizing reference genes. 
However, since such technologies for gene analysis are very expensive to acquire and perform38,39, if normal 
qRT-PCR is used, it appears crucial that studies account for all know reference genes and be based on reference 
primers that are optimized specifically for each experiment rather than relying on risky assumptions that refer-
ence genes used in a similar study also be adequate for this specific experiment.
A subsequent important limitation is RNA quality. This could be one of the reasons why our results in terms of 
stability and normalization quantity deviates from other groups results55,61,62. Research has established that there 
is a direct link between quality of RNA and qRT-PCR data. Is the quality poor, results can deviate considerably 
in gene expression patterns63. In the present study, we utilized a modified Trizol extraction procedure64 out of 
economic reasons, whose outcomes in RNA quantities are user-dependent. Since the quality of RNA was good for 
the present study with RINs being between 6 to 8, the variation in quality cannot as such be based on the method 
but rather the user who is doing the extraction65. This is a further limitation that possibly prevented consistency 
in generated results with other groups66,67. Four different users performed the method separately, for each of the 
cell lines and the tissue type, as these results are part of other experiments. We believe that more accurate data 
might have emerged from experiments conducted by a single user, and might have yielded results that would be 
similar to literature55,61,62,68.
In conclusion, qRT- PCR remains the best validated technique to economically generate accurate relative gene 
expression results, which, when properly standardized, are required to develop effective treatments for healing 
bone or cartilage defects. Attempts at translating from cell to animal and ultimately to human in most cases 
are probably failing because of inaccurate gene expression results from outsourced and non-viable qRT-PCR 
methods, as these require a lot of pre-optimizations. This is supported by the present results. However, reference 
genes are also genes and can be affected by experimental conditions. We therefore suggest not to use reference 
genes from other study groups, even if the same cell line or tissue type is utilized, as the reference genes can differ 
between experiments which can lead to inaccuracies in gene expression results. Taken in account together with 
the RNA quality, we recommend that for all future studies involving qRT-PCR, in bone and cartilage research, 
laboratories should ensure that their RNA quality is consistently good and before doing qRT-PCR according 
the guidelines of Bustin et al.31, determine which reference genes are suitable for their given experiments. This 
muct be done by utilizing all known reference genes and defining which are the most stable and how many refer-
ence genes are necessary to generate accurate results. Future research can then establish a general standard, with 
respect to stable reference genes for cell and tissue types in bone and cartilage regenerative research. This would 
enable future scientists in the field to always generate the most consistent, accurate and reproducible gene expres-
sion data. If these steps are not performed, we fear that bone and cartilage regeneration will remain problematic 
clinically.
Materials and Methods
Cell and Tissue Specimens. Cell and tissue types chosen are commonly utilized for studying chondrogenic 
or osteogenic differentiation or regeneration. Human ADSCs, hBMSCs, chondrocytes and muscle tissue from 
Rattus novericus where utilized in this optimization and standardization study. A total of 12 specimens per cell 
and tissue type were utilized with 6 specimens acting as the untreated cell or tissue group with the remaining 6 
specimens being treated to either undergo chondrogenic differentiation (all stem cells) or osteogenic differen-
tiation (tissue type). For hADSCs, cells were donated to our lab by Maryna et al.69, whereas chondrocytes and 
hBMSCs were obtained from Lonza (Lonza, Basel, Switzerland).
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Rattus novericus rectus abdomins muscle tissue was obtained by killing a F-344 adult male rat (Charles River 
Sulzbach, Germany) with an overdose of isoflurane (Abbot, Chicago, U.S.A.). This was done in accordance to 
the rules and regulations of the Animal Protection Laboratory Animal Regulations (2013), European Directive 
2010/63/EU and approved by the Animal ethics research committee (AESC) of the Ludwig Maximillian’s 
University of Munich (LMU), Bavaria, Germany Tierschutzgesetz §1/§4/§17 (https://www.gesetze-im-internet.
de/tierschg/TierSchG.pdf) with respect to animal usage for pure tissue or organ harvest only. Utilising 4 mm 
dermal biopsy punches (PFM medical, Cologne, Germany), 12 muscle tissue fragments were harvested. Six of the 
muscle fragments were treated to undergo osteogenesis utilising osteogenic medium (treatment) for 24 h, with the 
remaining six tissue fragments left untreated in DMEM. All tissue specimens were subsequently flash frozen in 
liquid nitrogen after which they were stored at −80 °C to be used for downstream molecular applications.
Chondrogenic differentiation. Human BMSCs and hADSCs were stimulated to undergo chondrogenic 
differentiation, to determine if reference genes remain the same within and between the two stem cell types 
or are differentially expressed. Briefly, after stem cells had entered the fourth passage, stem cell cultures were 
supplemented with chondrogenic differentiation medium comprised of DMEM–high glucose (DMEM-hg), 
10% fetal bovine serum, 100 units/ml penicillin, and 100 mg/ml streptomycin, 1x insulin-transferrin-selenium 
supplement (ITS + 1, Sigma-Aldrich), 50 µg/ml ascorbate 2-phosphate (Sigma-Aldrich), 40 µg/ml L-proline 
(Sigma-Aldrich),100 nm dexamethasone (Sigma-Aldrich), and 10 ng/ml rhTGF-β3 (R&D Systems, Minneapolis, 
U.S.A.). Every two days medium was changed, and cells cultured for 14 days to permit for differentiation. 
Chondrogenic differentiation was then confirmed via ACAN gene marker test, which is expressed only by dif-
ferentiated chondrocytes. Differentiated cells as well as untreated control cells were then flash frozen in liquid 
nitrogen to be used for downstream RNA and qRT-PCR standardisation protocols.
RNA extraction and cDNA synthesis. Harvested cells were disrupted under frozen conditions at 
3000 rpm for 1 min, using a Micro-Dismembrator S (Sartorius Stedim Biotech, Göttingen, Germany). Tissue spec-
imens were ground to powder utilising an Eppendorf mortar and pestle system in the presence of liquid Nitrogen. 
Total RNA was then isolated using a modified RNA Trizol extraction procedure70. Briefly, 1 ml Trizol (Invitrogen, 
San Diego, CA, USA) was added to the tissue or cell material after which chloroform (Sigma-Aldrich) was added 
to permit for the separation of the RNA from the proteinaceous material. After centrifugation, the aqueous RNA 
containing phase was transferred to a fresh tube where the RNA was then precipitated out by adding Isopropanol 
(Sigma-Aldrich). After incubation at RT for 10 min samples were centrifuged at 20000 rpm over-night at 4 °C, 
upon which RNA pellets were then washed with 75% ethanol (Merck, Billerica MA, U.S.A.) and permitted to 
dry thoroughly, to prevent alcohol contamination. After drying, total RNA was resuspended in 32 μl RNase free 
water (Gibco, California, U.S.A.) after which the concentration and purity of the RNA was determined using a 
NanoDropTMLite (Thermo Scientific, Waltham, U.S.A.) and quality assessed with a Bioanalyzer 2100 (Agilent 
Technologies, CA, U.S.A.). After RNA extraction, approximately 1 µg of RNA was reverse transcribed into com-
plementary DNA (cDNA) utilising the QuantiTect Reverse Transcription cDNA Synthesis Kit (Qiagen, Hilden, 
Germany). CDNA was stored at −20 °C.
Primer design and optimisation. Candidate reference genes were selected out of a gene library pool, 
known to be suitable reference genes optimal for the normalization of RNA qRT-qPCR expression studies, 
which focus on those with a standard deviation of the average amplification threshold cycles (Cq) of less than 
1 across 35 in human, rat, mouse cell and tissues60,71. Whilst a considerable number of different reference genes 
are known, for the present study 8 potential reference genes were selected; TATA-binding protein (TBP), glycer-
aldehyde 3-phosphate dehydrogenase (GAPDH), RNA 28S ribosomal 4 (RNA28S4), RNA polymerase II subunit e 
(POLR2e), ribosomal protein lateral stalk subunit P0 (RPLPO), succinate dehydrogenase complex flavoprotein sub-
unit A (SDHA), actin beta (ACTB), ribosomal protein L13a (RPL13a) (Table 2); as generally these are commonly 
and stably expressed in most cell and tissue types, taken into consideration with modern qRT-PCR techniques, 
where more than four reference genes is a rarity for generating accurate relative gene expression data.
The relevant sequences of all candidate reference genes (from Homo sapiens and Rattus novericus) were 
obtained from GenBank (http://www.ncbi.nlm.nih.gov/genbank/). Reference gene primer sequences were 
designed utilising PrimeQuest in conjunction with OligoAnalyzer 3.1 on the IDT website (https://eu.idtdna.
com/site) with specificity of the designed primer being confirmed through the use of the Basic Local Alignment 
Search Tool program on Pubmed Central (https://blast.ncbi.nlm.nih.gov/Blast.cgi).
Primers were optimised using a standard temperature gradient run to determine the optimal range of primer 
annealing temperatures, utilising 25 ng cDNA (from control cell or tissue samples), with 2x FastStart Essential 
DNA Green Master (Roche, Basel, Switzerland) and 10 µM of each primer (Table 2) in a final reaction volume 
of 10 µl. Runs were performed using a LightCycler® 96 thermocycler (Roche, Basel, Swiss), with thermocycling 
parameters including a pre-incubation of 3 min at 95 °C, followed by a three-step amplification programme of 40 
cycles consisting of a denaturation, annealing and extension step set at 95 °C for 10 s, 55 to 65 °C for 15 s and 72 °C 
for 30 s, respectively. A melt curve was included in each run to confirm amplification of a single product. After 
PCR amplification wells identified with positive amplicons were purified with the Mini Elute PCR Purification 
Kit (Qiagen, Crawley, UK), according to the manufacturer’s instructions and analysed, after Sanger sequencing 
(GATC Biotech, Cologne, Germany) utilising BLAST against the GenBank database to validate primer reference 
gene sequence amplification specificity.
Standardisation of cDNA quantity for qRT-PCR. In order to determine optimum cDNA quantity to 
be used per qRT-PCR reaction in cells and tissue samples a standard curve was utilised. A 2x dilution gradient 
of cDNA amounts, specifically 40 ng, 20 ng, 10 ng, 5 ng, 2.5 ng and 0 ng, was utilised to generate the standard 
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curve in relation to the Cq. PCR reactions were carried out in 96-well plates in duplicate. The PCR reactions 
were performed using a qRT-PCR LightCycler® 96 Instrument (Roche, Basel, Swiss), where the total volume per 
reaction was 10 μl, containing 10 μM of each reference primer (Table 2), the corresponding diluted cDNA and 
2x FastStart Essential DNA Green Master (Roche). Standardisation runs were performed using a LightCycler® 
96 thermocycler (Roche, Basel, Swiss), with thermocycling parameters possessing a pre-incubation of 3 min at 
95 °C, followed by a three step amplification programme of 40 cycles consisting of a denaturation, annealing and 
extension step set at 95 °C for 10 s, 60 °C for 15 s and 72 °C for 30 s, respectively. A melt curve was included in each 
run to validate product amplification. Standard curve results were summarised into a table showing the [cDNA] 
dilution in relation to the Cq value.
Reference primer expression stability and quantity. All reference primers were tested in hBMSCs 
and hADSCs undergoing chondrogenic differentiation, normal chondrocytes (with and without treatment) or rat 
muscle tissue to determine reference primer stability and how many reference primers were needed to generate 
accurate gene expression data. PCR reactions were carried out in 96-well plates in duplicate utilising a qRT-PCR 
LightCycler® 96 Instrument (Roche) with a total reaction volume of 10 μl, that contained 10 μM of each refer-
ence primer (Table 2), 10 ng of cDNA and 2x FastStart Essential DNA Green Master (Roche). Thermocycling 
parameters had a pre-incubation step of 3 min at 95 °C, followed by a three step amplification programme of 40 
cycles consisting of a denaturation, annealing and extension step set at 95 °C for 10 s, 60 °C for 15 s and 72 °C for 
30 s, respectively. A melt curve was included in each run to validate product amplification. Generated data was 
then inputted into GeNorm (http://medgen.ugent.be/wjvdesomp/genorm/) using the relative quantities based on 
comparative Cq method72. The statistical tools used by GeNorm were used to assess the expression stability of the 
candidate reference gene using the M-value, which refers to the average pairwise variation between each reference 
gene and the other reference genes. A gene with M <1.5 is considered as a stable reference gene. Subsequently, the 
pairwise variation (V-score) was determined which indicates the optimal number of reference genes to use for the 
cell or tissue type to generate realistic and accurate relative quantitative gene expression data27,72,73. The value of 
Vn/n + 1 under 0.15 indicates that no additional reference genes are required for normalization72.
Data and Code Availability
The necessary algorithmic codes of the program GeNorm are readily available at (http://medgen.ugent.be/
wjvdesomp/genorm/). All data, raw and processed, is readily available from the corresponding author on request.
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